Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
Lee-Sherick, A B, Eisenman, K M, Sather, S, McGranahan, A, Armistead, P M, McGary, C S, Hunsucker, S A, Schlegel, J, Martinson, H, Cannon, C, Keating, A K, Earp, H S, Liang, X, DeRyckere, D, Graham, D K
Published in Oncogene (14.11.2013)
Published in Oncogene (14.11.2013)
Get full text
Journal Article
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
Lee-Sherick, A B, Eisenman, K M, Sather, S, McGranahan, A, Armistead, P M, McGary, C S, Hunsucker, S A, Schlegel, J, Martinson, H, Cannon, C, Keating, A K, Earp, H S, Liang, X, DeRyckere, D, Graham, D K
Published in Oncogene (01.12.2016)
Published in Oncogene (01.12.2016)
Get full text
Journal Article
The small‐molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis
Branchford, B. R., Stalker, T. J., Law, L., Acevedo, G., Sather, S., Brzezinski, C., Wilson, K. M., Minson, K., Lee‐Sherick, A. B., Davizon‐Castillo, P., Ng, C., Zhang, W., Neeves, K. B., Lentz, S. R., Wang, X., Frye, S. V., Shelton Earp, H., DeRyckere, D., Brass, L. F., Graham, D. K., Di Paola, J. A.
Published in Journal of thrombosis and haemostasis (01.02.2018)
Published in Journal of thrombosis and haemostasis (01.02.2018)
Get full text
Journal Article
Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
Lee-Sherick, A B, Eisenman, K M, Sather, S, McGranahan, A, Armistead, P M, McGary, C S, Hunsucker, S A, Schlegel, J, Martinson, H, Cannon, C, Keating, A K, Earp, H S, Liang, X, DeRyckere, D, Graham, D K
Published in Oncogene (01.12.2016)
Published in Oncogene (01.12.2016)
Get full text
Journal Article